Obesity, insulin, and hypertension: Why outliers count

Journal of Hypertension

Volumn 32, Issue 4, 2014, Pages 740-741

  Jordan, Jens ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; INSULIN; LEPTIN; LEPTIN RECEPTOR; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; NITRIC OXIDE; NORADRENALIN; PROTEIN TYROSINE PHOSPHATASE 1B; MELANOCORTIN RECEPTOR;

ARCUATE NUCLEUS; BLOOD PRESSURE; EDITORIAL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC REGULATION; METABOLIC SYNDROME X; MUSCLE SYMPATHETIC NERVE ACTIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SYMPATHETIC TONE; URINARY EXCRETION; VASODILATATION; WEIGHT REDUCTION; COMPLICATION; FEMALE; MALE; PATHOPHYSIOLOGY; ADRENERGIC SYSTEM; DISEASE COURSE; DYSLIPIDEMIA; LEPTIN DEFICIENCY; NOTE; PATTERN RECOGNITION;

FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; OVERWEIGHT;

EID: 84896284403     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000117     Document Type: Editorial

References (18)

1. Lytsy P, Ingelsson E, Lind L, Ä rnlöv J, Sundström J. Interplay of overweight and insulin resistance on hypertension development. J Hypertens 2014; 32:834-839
2. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991; 87:2246-2252
3. Baron AD, Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 1995; 96:786-792
4. Hausberg M, Mark AL, Hoffman RP, Sinkey CA, Anderson EA. Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels. J Hypertens 1995; 13:1015-1021
5. Hausberg M, Hoffman RP, Somers VK, Sinkey CA, Mark AL, Anderson EA. Contrasting autonomic and hemodynamic effects of insulin in healthy elderly versus young subjects. Hypertension 1997; 29:700-705
6. Straznicky NE, Grima MT, Sari CI, Eikelis N, Lambert EA, Nestel PJ, et al. Neuroadrenergic dysfunction along the diabetes continuum: A comparative study in obese metabolic syndrome subjects. Diabetes 2012; 61:2506-2516
7. Grassi G, Dell'Oro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F, et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005; 48:1359-1365
8. Grassi G, Seravalle G, Colombo M, Bolla G, Cattaneo BM, Cavagnini F, et al. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 1998; 97:2037-2042
9. Belin De Chantemele EJ, Ali MI, Mintz JD, Rainey WE, Tremblay ML, Fulton DJ, et al. Increasing peripheral insulin sensitivity by protein tyrosine phosphatase 1B deletion improves control of blood pressure in obesity. Hypertension 2012; 60:1273-1279
10. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: New insights into mechanisms. Hypertension 2005; 45:9-14
11. Hall JE, Da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, et al. Obesity-induced hypertension: Role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem 2010; 285:17271-17276
12. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999; 84:3686-3695
13. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009; 360:44-52
14. Weyer C, Pratley RE, Snitker S, Spraul M, Ravussin E, Tataranni PA. Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure. Hypertension 2000; 36:531-537
15. Bisquolo VA, Cardoso CG Jr, Ortega KC, Gusmao JL, Tinucci T, Negrao CE, et al. Previous exercise attenuates muscle sympathetic activity and increases blood flow during acute euglycemic hyperinsulinemia. J Appl Physiol 19852005; 98:866-871
16. Sohn JW, Harris LE, Berglund ED, Liu T, Vong L, Lowell BB, et al. Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons. Cell 2013; 152:612-619
17. Ward KR, Bardgett JF, Wolfgang L, Stocker SD. Sympathetic response to insulin is mediated by melanocortin 3/4 receptors in the hypothalamic paraventricular nucleus. Hypertension 2011; 57:435-441
18. Luckett BS, Frielle JL, Wolfgang L, Stocker SD. Arcuate nucleus injection of an anti-insulin affibody prevents the sympathetic response to insulin. Am J Physiol Heart Circ Physiol 2013; 304:H1538-H1546